Pfizer Inc and partner BioNTech SE said Friday they have submitted new data to the U.S. health regulator showing the stability of their Covid-19 vaccine at temperatures commonly found in pharmaceutical freezers and refrigerators.
Pfizer/BioNTech’s vaccine, along with Moderna Inc’s two-dose vaccine, won the U.S. emergency use authorization (EUA) and is being widely distributed as part of the country’s mass vaccination efforts.
If approved, the less onerous storage requirements would provide a big logistical relief because the vaccine, for now, has to be stored at minus 70 degrees Celsius for longer periods, a challenge particularly in lower-income countries that don’t have the u…
Keep on reading: Pfizer submits data showing Covid-19 vaccine’s stability in refrigerators